# Quantitative Quality-Control Consistency Review — JAMA 2025.9110

## Pending Human Adjudication

**All six quality-control candidates in this report are Pending Human Adjudication.** This review records supplied-source reporting inconsistencies for human assessment; it assigns no validity decision, importance ranking, correction, or conclusion about the study.

## Executive Quality-Control Summary

This Workflow 1.5.1 review completed source-linked quantitative consistency coverage of four supplied PDFs (115 PDF pages). It registered **6 distinct candidates (C001–C006)** after duplicate merging, direct-PDF evidence recheck, and independent two-pass statistical review. The candidates concern summary-statistic labels or table notation. They are reporting-quality questions, not findings that the trial conclusion is incorrect.

Small preventable reporting defects can matter when numeric results are later copied into systematic reviews, meta-analyses, guidelines, or structured evidence databases. That downstream possibility is stated conditionally throughout: this review does not assert that any propagation, conclusion change, or harm occurred.

## Package and Reused-Evidence Provenance

The direct-source package contains four PDFs and no Office, workbook, or CSV source. The source inventory and pre-review SHA-256 record are [source_inventory.md](review_1_5_1/source_inventory.md) and [source_hashes_before.sha256](review_1_5_1/source_hashes_before.sha256).

| Source | PDF pages | SHA-256 |
|---|---:|---|
| `jama_summers_2025_oi_250040_1753124024.36498.pdf` | 10 | `a2ee3c43b8f4285d254fc612c70921aecdfc881230f3c70c580b0e8ba988ba4a` |
| `joi250040supp1_prod_1753124024.37199.pdf` | 40 | `6745568ae794f5ec8828c9c873d4926fc84007a81a36a391b392cd43559b7521` |
| `joi250040supp2_prod_1753124024.37799.pdf` | 31 | `2b3cba9e9c65ceb237a5a9b4de2ac7d5774ed74f9a4ae509ef30898572e62071` |
| `joi250040supp3_prod_1753124024.38098.pdf` | 34 | `fc3711231839990ce5ce604ba1c154e85678df82e7cb9d9d46c2170bd5f94e9c` |

Existing source-linked native text, normalized text, OCR, rendered pages, manifests, and evidence maps were reused only as locators and transcription aids. Their inventory, fitness assessment, and pre-review hashes are in [evidence_asset_inventory.md](review_1_5_1/evidence_asset_inventory.md) and [reused_artifact_hashes_before.sha256](review_1_5_1/reused_artifact_hashes_before.sha256). Direct PDFs remained the authority for every candidate recheck.

## Scope, Complete Coverage, and Exclusions

| Coverage measure | Count |
|---|---:|
| Direct sources | 4 |
| Total source units | 115 PDF pages |
| Reusable-backed units | 42 |
| Fresh direct-source units | 73 |
| Mapped units | 115 |

All direct-source rows are complete: main article 10/10 pages, protocol 40/40, SAP 31/31, and Results Supplement 34/34. Reusable and fresh-required units partition each direct-source page set. The page-level assignments and all stage artifacts are recorded in [source_coverage.md](review_1_5_1/source_coverage.md) and [coverage_manifest.md](review_1_5_1/coverage_manifest.md).

The review was limited to quantitative reporting consistency: numeric values, denominators/proportions/totals, inferential statistics, cross-document values, effect measures/labels/scales, and rate-versus-count relationships. It did not conduct a broad clinical, methodological, raw-data, misconduct, novelty, or literature review. Prospective protocol/SAP/PRO-SCAN and external-feasibility statements were not treated as final-result contradictions unless population, time, contrast, estimand, and analysis context matched.

## Quantitative and Statistical Relationship Coverage

The canonical numeric inventory contains **N001–N068 (68 distinct relationships; 80 provisional occurrences crosswalked)**. The canonical statistical inventory contains **S001–S036 (36 distinct relationships; 41 provisional occurrences crosswalked)**. Together, 104 global relationships were checked in numeric and cross-source lanes. See [numeric relationship inventory](review_1_5_1/relationships/numeric_relationship_inventory.md) and [statistical relationship inventory](review_1_5_1/statistics/relationship_inventory.md).

Statistical pass 1 independently completed S001–S036 and emitted no local candidate; statistical pass 2 independently completed S001–S036, reviewed the complete cross-lane ledger and recheck facts, and supplied two new distinct eTable-10 notation candidates (C005–C006). Both passes are complete in [statistical pass 1](review_1_5_1/checkers/statistical_pass_1.md) and [statistical pass 2](review_1_5_1/checkers/statistical_pass_2.md). The prior locator transcription question for the renal/RRT interaction was directly reconciled: the supplied Results Supplement pages print `P<0.001` at both locations, so it is a corrected noncandidate. No candidate was created from a coherent display-zero P value.

## Candidate Index

| ID | Candidate | Category | Primary location |
|---|---|---|---|
| [C001](#c001) | Invasive-ventilation descriptive summary labeled mean (SD) but displays two endpoints | Measure, label, or scale inconsistency | [Main PDF p. 7](<../jama_summers_2025_oi_250040_1753124024.36498.pdf#page=7>) |
| [C002](#c002) | One eTable 10 survival percentage uses a comma | Measure, label, or scale inconsistency | [Results Supplement PDF p. 18](<../joi250040supp3_prod_1753124024.38098.pdf#page=18>) |
| [C003](#c003) | Bayesian quantile row labeled mean (SD) despite median estimand | Measure, label, or scale inconsistency | [Main PDF p. 7](<../jama_summers_2025_oi_250040_1753124024.36498.pdf#page=7>) |
| [C004](#c004) | Discussion calls day-10 urea summaries means while Results reports medians (IQR) | Cross-document numeric inconsistency | [Main PDF pp. 5 and 8](<../jama_summers_2025_oi_250040_1753124024.36498.pdf#page=5>) |
| [C005](#c005) | eTable 10 tracheostomy row switches percent-sign notation | Measure, label, or scale inconsistency | [Results Supplement PDF p. 18](<../joi250040supp3_prod_1753124024.38098.pdf#page=18>) |
| [C006](#c006) | eTable 10 new-KRT row switches percent-sign notation | Measure, label, or scale inconsistency | [Results Supplement PDF p. 18](<../joi250040supp3_prod_1753124024.38098.pdf#page=18>) |

## Candidate Evidence Cards

## C001 — Invasive-ventilation descriptive summary is labeled mean (SD) but displays two endpoints

**Candidate statement:** The invasive-ventilation Table 2 row is labeled `mean (SD)` but each group display contains two endpoints.

**Category:** Measure, label, or scale inconsistency

**Exact source locations:** [Main article — PDF p. 7](<../jama_summers_2025_oi_250040_1753124024.36498.pdf#page=7>), Table 2, `Duration of invasive ventilation, mean (SD), h`; [main article — PDF p. 1](<../jama_summers_2025_oi_250040_1753124024.36498.pdf#page=1>); [Results Supplement — PDF p. 18](<../joi250040supp3_prod_1753124024.38098.pdf#page=18>), eTable 10.

**Source evidence:** Table 2 prints augmented protein `84.0 (35.0 to 178.9)` and usual protein `78.0 (33.2 to 161.0)`, while the row label says `mean (SD)`. It separately prints `Mean difference, 6.8 (−3.0 to 16.5)` hours. eTable 10 describes comparable central-value/two-bound summaries as median (IQR).

**Reported-versus-comparator:** The printed `mean (SD)` label is compared with the two-endpoint parenthetical displays and the supplementary median (IQR) presentation convention.

**Reasoning procedure:** Compare the descriptive label with the number and form of values printed inside each group parenthesis; keep the model-based mean difference distinct from the group descriptive display.

**Calculation:** `35.0 < 178.9` and `33.2 < 161.0`; each parenthesis has two ordered endpoints, not one SD. No rounding rule applies.

**Alternative source-grounded interpretations:** `to` or an endpoint may be a production error in an intended mean/SD display; alternatively the label may be wrong and the values may be a median-plus-interval summary. The supplied package does not define the endpoints.

**Mechanical evidence recheck:** Direct PDF-page review confirmed the label, both displays, and the separate mean-difference effect; [evidence recheck](review_1_5_1/verification/evidence_recheck.md) records the missing definition without adjudication.

**Quality-control relevance:** The printed form can cause a data extractor to record an interval as an SD or misidentify the descriptive statistic for a duration outcome.

**Potential downstream evidence impact:** If confirmed, a systematic reviewer, meta-analyst, guideline developer, or data extractor could copy the wrong summary type or dispersion representation for invasive-ventilation duration; no propagation or conclusion change is asserted.

**Human verification steps:** Confirm the intended descriptive statistic and interval/dispersion from the publication proof or author source, then determine whether the label or the displayed values should be corrected.

**Human adjudication fields:**
- **Validity:** __
- **Importance:** __
- **Action:** __
- **Initials:** __
- **Notes:** __

## C002 — eTable 10 uses a comma in one one-decimal survival percentage

**Candidate statement:** One eTable 10 day-90 survival percentage uses a comma-and-space where matched cells use a decimal point.

**Category:** Measure, label, or scale inconsistency

**Exact source locations:** [Results Supplement — PDF p. 18](<../joi250040supp3_prod_1753124024.38098.pdf#page=18>), eTable 10, `Alive at day 90 [n (%)]`, Period 2 usual protein (4 units, `n = 530`).

**Source evidence:** The cell prints `383 (72, 3%)`; neighboring matched cells include `323 (67.3%)`, `258 (77.0%)`, `229 (76.8%)`, and `408 (74.0%)`.

**Reported-versus-comparator:** `72, 3%` is compared with the row's point-decimal convention and its printed count/denominator.

**Reasoning procedure:** Reproduce the one-decimal percentage from the supplied numerator and denominator, then compare its punctuation to matched cells in the same English table.

**Calculation:** `383 / 530 × 100 = 72.2641509…%`, which rounds to `72.3%` at one decimal (rounding interval 72.25% to <72.35%). The question is punctuation, not a numerator/denominator mismatch.

**Alternative source-grounded interpretations:** A comma can be a decimal separator in some locales and preserve the intended numeric value, but its isolated use in this point-decimal table remains a rendering inconsistency.

**Mechanical evidence recheck:** Direct page inspection confirmed the comma, count, denominator, and surrounding point decimals; the recheck reproduced the arithmetic.

**Quality-control relevance:** The punctuation can impair consistent manual or automated extraction of a period-specific survival percentage.

**Potential downstream evidence impact:** If confirmed, an evidence extractor could transcribe or parse this period-specific percentage inconsistently; no propagation or changed trial conclusion is asserted.

**Human verification steps:** Confirm whether the comma-and-space is intentional and, if not, standardize the cell to the table's point-decimal convention.

**Human adjudication fields:**
- **Validity:** __
- **Importance:** __
- **Action:** __
- **Initials:** __
- **Notes:** __

## C003 — Bayesian quantile row is labeled mean (SD) despite its associated median estimand and two-endpoint group displays

**Candidate statement:** The Bayesian quantile Table 2 row is labeled `mean (SD)` despite a median-difference estimand and two-endpoint group displays.

**Category:** Measure, label, or scale inconsistency

**Exact source locations:** [Main article — PDF p. 7](<../jama_summers_2025_oi_250040_1753124024.36498.pdf#page=7>), Table 2; [Results Supplement — PDF p. 5](<../joi250040supp3_prod_1753124024.38098.pdf#page=5>), secondary analyses; [Results Supplement — PDF p. 27](<../joi250040supp3_prod_1753124024.38098.pdf#page=27>), eFigure 6.

**Source evidence:** The row prints `62.0 (0 to 77)` versus `64.0 (0 to 77)` under `mean (SD)` and reports `Median difference, −1.50 (−3.86 to 0.90)`. The supplement defines the Bayesian quantile coefficient as a difference in medians and repeats the median difference with a 95% credible interval.

**Reported-versus-comparator:** The Table 2 `mean (SD)` group-summary label is compared with its own median-difference effect label, the final Bayesian method description, and the two-bound group displays.

**Reasoning procedure:** Match outcome, population, contrast, and Bayesian model across locations; test whether a one-SD descriptive form is actually printed.

**Calculation:** `0 < 77` in each group parenthesis, so each contains two bounds rather than one SD. The printed estimand is `Median difference`; no supplied text explains an intentional separate mean/SD convention.

**Alternative source-grounded interpretations:** The label may have carried over from the preceding linear-model row. Separately calculated means/SDs might have been intended alongside a median estimand, but the source neither defines that convention nor explains the two endpoints.

**Mechanical evidence recheck:** Direct PDF review confirmed all labels, values, method wording, and eFigure result; no source identifies the intended group-summary definition.

**Quality-control relevance:** The label may lead extractors to misclassify the descriptive summary and analysis-scale context for the primary outcome.

**Potential downstream evidence impact:** If confirmed, downstream evidence users could copy an incorrect summary type or analysis-scale description; no propagation or conclusion change is asserted.

**Human verification steps:** Identify the intended statistic and interval for the two group displays and confirm whether `mean (SD)` was intended or carried over.

**Human adjudication fields:**
- **Validity:** __
- **Importance:** __
- **Action:** __
- **Initials:** __
- **Notes:** __

## C004 — Discussion describes the matched day-10 urea summaries as means while Results reports medians (IQR)

**Candidate statement:** The Discussion calls the matched day-10 blood-urea summaries means while Results reports medians (IQR).

**Category:** Cross-document numeric inconsistency

**Exact source locations:** [Main article Results — PDF p. 5](<../jama_summers_2025_oi_250040_1753124024.36498.pdf#page=5>), Biochemical Outcomes; [main article Discussion — PDF p. 8](<../jama_summers_2025_oi_250040_1753124024.36498.pdf#page=8>).

**Source evidence:** Results calls day-10 blood-urea values median (IQR): augmented protein `13.0 (8.2–18.8)` versus usual protein `10.6 (7.1–15.4)` mmol/L. Discussion says that `mean urea concentrations at day 10 were higher in the augmented protein group`.

**Reported-versus-comparator:** The Discussion's `mean` label is compared with the Results' matched analyte, day, groups, direction, unit, and `median (IQR)` description.

**Reasoning procedure:** Match population, analyte, time point, contrast, direction, and unit, then compare the stated summary-statistic terms without reconstructing a mean from medians/IQRs.

**Calculation:** No calculation is appropriate: mean and median are distinct summary-statistic labels, and no matched day-10 mean values are supplied.

**Alternative source-grounded interpretations:** `Mean` may be nontechnical prose, a copy-editing substitution, or a reference to unprinted group means. The supplied package does not report a distinct matched mean analysis.

**Mechanical evidence recheck:** Direct page review confirmed the Results label/values and the Discussion wording; the recheck found agreement in direction but no printed matched mean values.

**Quality-control relevance:** A reader or data extractor could report the wrong summary-statistic type for the biochemical result.

**Potential downstream evidence impact:** If confirmed, a downstream extractor could record means instead of the reported medians/IQRs for day-10 urea; no propagation or changed conclusion is asserted.

**Human verification steps:** Determine whether the Discussion sentence refers to the printed median comparison or a distinct mean analysis; if distinct, identify its values and definition.

**Human adjudication fields:**
- **Validity:** __
- **Importance:** __
- **Action:** __
- **Initials:** __
- **Notes:** __

## C005 — eTable 10 tracheostomy row switches percent-sign notation across period cells

**Candidate statement:** The eTable 10 tracheostomy row changes percent-sign notation halfway across matched period cells.

**Category:** Measure, label, or scale inconsistency

**Exact source locations:** [Results Supplement — PDF p. 18](<../joi250040supp3_prod_1753124024.38098.pdf#page=18>), eTable 10, `Tracheostomy in ICU [n (%)]`.

**Source evidence:** The first four cells print `27 (5.6)`, `36 (10.7)`, `29 (9.7)`, and `24 (4.5)` without `%`; the last four print `35 (6.4%)`, `38 (10.3%)`, `43 (12.2%)`, and `23 (4.8%)` with `%`.

**Reported-versus-comparator:** All eight are percentage displays in one `[n (%)]` row, but the first four omit `%` and the last four include it.

**Reasoning procedure:** Use the row header and printed column denominators to establish the shared percentage field, reproduce the first-four values, and compare notation across cells.

**Calculation:** `27/480×100=5.625%→5.6%`; `36/335×100=10.746…%→10.7%`; `29/298×100=9.732…%→9.7%`; `24/530×100=4.528…%→4.5%`. These reconcile at one decimal (0.05 percentage-point rounding tolerance); the issue is notation, not arithmetic.

**Alternative source-grounded interpretations:** The `[n (%)]` header makes the unsigned entries understandable, but it does not explain the within-row switch to explicit signs. Intended typography is not stated.

**Mechanical evidence recheck:** Direct page inspection confirmed all eight cells, denominators, and notation split; the recheck reproduced the percentages and found no rate/count discrepancy.

**Quality-control relevance:** Mixed notation can produce inconsistent manual or automated parsing of period-specific tracheostomy percentages.

**Potential downstream evidence impact:** If confirmed, a systematic reviewer, meta-analyst, guideline developer, or data extractor could copy or parse the period-specific percentages inconsistently; no propagation or conclusion change is asserted.

**Human verification steps:** Confirm whether the switch was intentional and select one percent-sign convention for all eight tracheostomy cells.

**Human adjudication fields:**
- **Validity:** __
- **Importance:** __
- **Action:** __
- **Initials:** __
- **Notes:** __

## C006 — eTable 10 new-KRT row switches percent-sign notation across period cells

**Candidate statement:** The eTable 10 new-kidney-replacement-therapy row changes percent-sign notation halfway across matched period cells.

**Category:** Measure, label, or scale inconsistency

**Exact source locations:** [Results Supplement — PDF p. 18](<../joi250040supp3_prod_1753124024.38098.pdf#page=18>), eTable 10, `New kidney replacement therapy commenced during index ICU admission after commencing trial enteral nutrition [n (%)]`.

**Source evidence:** The first four cells print `33 (6.9)`, `26 (7.8)`, `22 (7.4)`, and `35 (6.6)` without `%`; the last four print `38 (6.9%)`, `33 (9.0%)`, `29 (8.2%)`, and `33 (6.8%)` with `%`.

**Reported-versus-comparator:** All eight are percentage displays within one `[n (%)]` row, but `%` is absent from the first four and present in the final four.

**Reasoning procedure:** Use the shared row header and printed denominators to identify the common percentage field, reproduce the unsigned values, then compare notation across the row.

**Calculation:** `33/480×100=6.875%→6.9%`; `26/335×100=7.761…%→7.8%`; `22/298×100=7.383…%→7.4%`; `35/530×100=6.604…%→6.6%`. All reconcile at one decimal (0.05 percentage-point rounding tolerance); the issue is notation, not a rate/count discrepancy.

**Alternative source-grounded interpretations:** The row header makes unsigned values interpretable as percentages, but the source gives no reason why only the final four cells carry `%` or which convention was intended.

**Mechanical evidence recheck:** Direct page inspection confirmed every target cell, the denominator basis, and the percent-sign split; arithmetic reproduced the displayed values.

**Quality-control relevance:** The within-row notation change can create inconsistent extraction of period-specific KRT percentages.

**Potential downstream evidence impact:** If confirmed, a systematic reviewer, meta-analyst, guideline developer, or data extractor could copy or parse period-specific KRT percentages inconsistently; no propagation or conclusion change is asserted.

**Human verification steps:** Confirm whether the switch was intentional and select one percent-sign convention for all eight new-KRT cells.

**Human adjudication fields:**
- **Validity:** __
- **Importance:** __
- **Action:** __
- **Initials:** __
- **Notes:** __

## Downstream Evidence-Chain Considerations

If a candidate is confirmed, later evidence products may copy a descriptive-statistic label, a decimal rendering, or percent-sign convention exactly as printed. This is why minor-looking consistency questions are preserved for human review. The supplied package does not establish that any later product copied these values, that an effect estimate changed, or that a clinical or study conclusion changed.

## Limitations and Missing Definitions

The package lacks participant-level data, analysis datasets, fitted model objects, and complete inferential internals; model-based results therefore were not independently refitted. Corrected-GEE and cause-specific-Cox reports do not fully state the common test statistic, interval construction, variance-estimator application, and sidedness needed for decisive manual P/CI reconstruction. Bootstrap quantile and Bayesian credible intervals were not treated as normal-theory intervals.

The prospective protocol, SAP, PRO-SCAN, and external-feasibility materials are not matched final-result comparators by default. Candidate-specific missing definitions remain: C001's two endpoints, C003's Bayesian-row group summaries, and C004's possible distinct day-10 mean analysis are not defined in the supplied sources. C002 does not state whether the comma was intentional; C005–C006 do not state the intended percent-sign convention. Reused derivatives served only as locators; no production proof, author manuscript, or correction history is supplied. The complete limitation record is [limitations.md](review_1_5_1/limitations.md).

## Human Adjudication Checklist

For each C ID, inspect the cited direct PDF page(s), confirm the exact printed form and comparator, identify any author/proof evidence outside this supplied package if available to the human reviewer, record the five blank adjudication fields on the card, and preserve the original stable ID regardless of the adjudication outcome. This report does not assign severity, acceptance, rejection, correction, or final disposition.

## Reproducibility, Source-Integrity, Agent-Execution, Performance, Token-Usage, and Cost Metadata

### Reproducibility and source integrity

The full review state, page coverage, relationship inventories, checker outputs, candidate ledger, evidence recheck, and quality audit are preserved under [review_1_5_1](review_1_5_1/). Candidate source links point to supplied direct PDF pages; reusable derivatives are provenance aids only. Recomputed [direct-source hashes](review_1_5_1/source_hashes_after.sha256) exactly match the baseline, and recomputed [reused-artifact hashes](review_1_5_1/reused_artifact_hashes_after.sha256) exactly match their baseline; no supplied source or reused artifact changed during review.

### Agent execution

| Stage | Runtime agent ID | Model | Reasoning effort | Start mode | Output artifact |
|---|---|---|---|---|---|
| coordinator | `COORDINATOR-CURRENT-SESSION` | gpt-5.6-sol | high | CURRENT_SESSION | `run_state.md` |
| reuse asset curator | `reuse_asset_curator` | gpt-5.6-terra | medium | FRESH_SPAWN | `evidence_asset_inventory.md` |
| main quantitative mapper | `main_mapper` | gpt-5.6-terra | medium | FRESH_SPAWN | `extraction/main_quantitative_evidence.md` |
| protocol mapper 1 | `support_protocol_1` | gpt-5.6-terra | medium | FRESH_SPAWN | `parts/support_protocol_pp01-32.md` |
| protocol mapper 2 | `support_protocol_2` | gpt-5.6-terra | medium | FRESH_SPAWN | `parts/support_protocol_pp33-40.md` |
| SAP mapper | `support_sap` | gpt-5.6-terra | medium | FRESH_SPAWN | `parts/support_sap_pp01-31.md` |
| Results Supplement mapper 1 | `support_results_1` | gpt-5.6-terra | medium | FRESH_SPAWN | `parts/support_results_supp_pp01-32.md` |
| Results Supplement mapper 2 | `support_results_2` | gpt-5.6-terra | medium | FRESH_SPAWN | `parts/support_results_supp_pp33-34.md` |
| numeric consistency reviewer | `numeric_checker` | gpt-5.6-terra | medium | FRESH_SPAWN | `checkers/numeric_consistency.md` |
| cross-source consistency reviewer | `cross_source_checker` | gpt-5.6-terra | medium | FRESH_SPAWN | `checkers/cross_source_consistency.md` |
| statistical pass 1 | `statistical_pass_1` | gpt-5.6-terra | high | FRESH_SPAWN | `checkers/statistical_pass_1.md` |
| evidence rechecker | `evidence_rechecker` | gpt-5.6-sol | high | FRESH_SPAWN | `verification/evidence_recheck.md` |
| statistical pass 2 | `statistical_pass_2` | gpt-5.6-terra | high | FRESH_SPAWN | `checkers/statistical_pass_2.md` |
| evidence quality auditor | `quality_auditor` | gpt-5.6-sol | high | FRESH_SPAWN | `quality/evidence_quality_audit.md` |
| report generator | `report_generator` | gpt-5.6-terra | medium | FRESH_SPAWN | `report_generation.md` |

The authoritative execution manifest is [agent_execution_manifest.md](review_1_5_1/agent_execution_manifest.md).

### Performance

- **Target basis:** Four-PDF package with 115 total pages; 42 pages have source-matched reusable page-level extraction, while 73 pages require fresh direct-source mapping, including 71 protocol/SAP pages whose embedded text is known to be garbled and may require CPU rendering/OCR; the package also contains dense tables and figures requiring cross-source and two-pass statistical review. Relative to the 102-page/81-fresh calibration run, total scope and visual complexity support a bounded 50-75 minute planning range.
- **Total source units:** 115
- **Fresh-source units:** 73
- **Target elapsed minutes:** 50-75
- **Started UTC:** 2026-09-03T03:51:44Z
- **Finished UTC:** 2026-09-03T07:12:42Z
- **Observed elapsed minutes:** 201.0
- **Target status:** EXCEEDED_TARGET
- **Exceedance causes:** CPU-only rendering and direct visual mapping of 71 previously uncovered protocol/SAP pages with unusable encoded text; severe shared-host CPU and swap contention; lossless consolidation of 121 provisional relationships; required direct-source rechecks and owner-specific artifact/link repairs

### Token accounting and cost

- **Token accounting status:** INCOMPLETE_RUNTIME_USAGE_UNAVAILABLE
- **Total-token count status:** INCOMPLETE
- **Total tokens:** 0
- **Known token cost (USD):** 0.000000
- **Estimated complete token cost (USD):** __

| Model | Input tokens | Output tokens | Total tokens | Token-only API-equivalent estimate (USD) |
|---|---:|---:|---:|---:|
| gpt-5.6-sol | 0 | 0 | 0 | 0.000000 known; complete __ |
| gpt-5.6-terra | 0 | 0 | 0 | 0.000000 known; complete __ |

The runtime exposed no authoritative token counts for the coordinator or any manifested specialist response. Each of the 15 agents therefore has an explicit `UNAVAILABLE` ledger record; no token count was estimated from text. The displayed zero is the known subtotal only and is not a complete package token count or cost. See [token_usage_ledger.csv](review_1_5_1/token_usage_ledger.csv) and [token_usage_summary.md](review_1_5_1/token_usage_summary.md). Cached input/cache-write counts are input subsets and reasoning is an output subset; none is added again to total tokens. Any cost is a token-only API-equivalent estimate under the dated price snapshot, not an invoice.
